Suchergebnisse - "IgG"

PubPharm (132)

1

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023

enthalten in: Emerging infectious diseases | 2024

von Lustig, Y. | Canetti, M. | Indenbaum, V. | +11

2

Immunogenicity of Two Doses of BNT162b2 mRNA COVID-19 Vaccine with a ChAdOx1-S Booster Dose among Navy Personnel in Mexico

enthalten in: Viruses | 2024

von Ventura-Enríquez, Y. | Cortina-De la Rosa, E. | Díaz-Padilla, E. | +4

3

SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters

enthalten in: Journal of virology | 2024

von Hsieh, M. | Hsu, C. | Liao, H. | +6

4

Dynamics of serum cross-neutralization capacity against SARS-CoV-2 Delta variant in convalescent COVID-19 patients

enthalten in: Journal of medical virology | 2024

von Nedelcu, I. | Florian, P. | Ion, D. | +4

5

Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination

enthalten in: Virus research | 2024

von Ota, K. | Sakai, H. | Sasaki, D. | +10

6

Factors associated with IgG titers against SARS-CoV-2 spike protein after second vaccination in people living with HIV controlled with anti-retroviral therapy

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Lee, K. | Horino, T. | Hoshina, T. | +6

7

Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies

enthalten in: Biomedical journal | 2024

von Reinig, S. | Shih, S.

8

Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan

enthalten in: BMC infectious diseases | 2023

von Masood, K. | Qaiser, S. | Abidi, S. | +23

9

Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits

enthalten in: Viruses | 2023

von Awasthi, M. | Macaluso, A. | Goebel, S. | +6

10

SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines

enthalten in: Human vaccines & immunotherapeutics | 2023

von Hickey, T. | Kemp, T. | Bullock, J. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]